C57BL/6N-Jarid2tm2(EGFP/cre/ERT2)Wtsi/Cnrm

Status

Available to order

EMMA IDEM:10018
International strain nameC57BL/6N-Jarid2tm2(EGFP/cre/ERT2)Wtsi/Cnrm
Alternative nameCEPD0096_1_A05
Strain type
Allele/Transgene symbolJarid2tm2(EGFP/cre/ERT2)Wtsi
Gene/Transgene symbolJarid2

Information from provider

Provider CNR, Consiglio Nazionale delle Ricerche
Provider affiliationEMMA-Monterotondo Campus International Development, CNR, Consiglio Nazionale delle Ricerche
Genetic informationThis mouse line originates from EUCOMM ES clone CEPD0096_1_A05. For further details on the construction of this clone see the page at the IMPC portal.
Quality Control/Disclaimer: The structure of the targeted mutation is not fully verified. It is recommended that the recipient confirms the mutation structure by Southern blotting. The Cre expression pattern is expected to mirror that of the host gene, but this may not be fully described and/or may be modified in the targeted allele. Although characterisation of the Cre expression pattern is an objective of EUCOMMTools this is an ongoing process which may be incomplete. It is therefore recommended that the recipient verifies the Cre expression pattern. For the tm2(EGFP/Cre/ERT2) type allele, if the promoter-driven selection cassette is flanked with Rox sites, it may be removed using Dre recombinase. Please be aware that the strain description may be subject to change. For the most recent description please consult the information pages for the appropriate product details at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • decreased circulating magnesium level / IMPC
  • increased circulating creatinine level / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
MGI phenotypes (gene matching)
  • abnormal sternum morphology / MGI
  • abnormal erythropoiesis / MGI
  • abnormal heart development / MGI
  • abnormal myocardial fiber morphology / MGI
  • abnormal interventricular septum morphology / MGI
  • double outlet right ventricle / MGI
  • distended pericardium / MGI
  • trabecula carnea hypoplasia / MGI
  • abnormal liver morphology / MGI
  • liver hypoplasia / MGI
  • small liver / MGI
  • enlarged liver sinusoidal spaces / MGI
  • decreased hepatocyte number / MGI
  • abnormal liver physiology / MGI
  • spleen hypoplasia / MGI
  • incomplete rostral neuropore closure / MGI
  • anemia / MGI
  • hepatic necrosis / MGI
  • decreased embryo size / MGI
  • edema / MGI
  • thymus hypoplasia / MGI
  • hemorrhage / MGI
  • respiratory failure / MGI
  • prenatal lethality / MGI
  • abnormal definitive hematopoiesis / MGI
  • abnormal neural tube morphology / MGI
  • abnormal myocardial trabeculae morphology / MGI
  • abnormal megakaryocyte progenitor cell morphology / MGI
  • delayed neural tube closure / MGI
  • thin myocardium / MGI
  • abnormal fetal cardiomyocyte proliferation / MGI
  • nervous system phenotype / MGI
  • abnormal neural tube closure / MGI
  • abnormal nervous system development / MGI
  • abnormal heart left ventricle morphology / MGI
  • abnormal interventricular groove morphology / MGI
  • abnormal myocardium compact layer morphology / MGI
  • dilated heart right atrium / MGI
  • fetal growth retardation / MGI
  • abnormal thoracic cage morphology / MGI
  • abnormal neural fold formation / MGI
  • abnormal myocardium layer morphology / MGI
  • increased circulating creatinine level / MGI
  • abnormal neural plate morphology / MGI
  • abnormal splenic cell ratio / MGI
  • abnormal thymus cell ratio / MGI
  • ventricular septal defect / MGI
  • abnormal coronary vessel morphology / MGI
  • perinatal lethality, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • lethality throughout fetal growth and development, complete penetrance / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI
  • lethality throughout fetal growth and development, incomplete penetrance / MGI
  • decreased fetal derived definitive erythrocyte cell number / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).